Immunotherapy of Lung Tumors
Lung cancer demography 85 % of lung tumors are NSCLCs 15 % of lung tumors are SCLCs 45 % of NSCLC cases are adenocarcinoma 45 % of NSCLC are squamous…
Cancer Immunotherapy Confers a Global Benefit
Fig. 1.1 Estimated age-standardized incidence of overall cancers per 100,000 in different countries (Extracted from) More than the environment, host-related characteristics are also major determinants of cancer incidence. Since cancer…
Immunopathology and Immunotherapy of Central Nervous System Cancer
Fig. 18.1 Polarization of tumor-associated macrophages in glioma. Notice the distinct M1 and M2 phenotypes (Reprinted from Li and Graeber [18], with permission) Alternatively activated M2-type TAMs are the predominant…
Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers
Fig. 13.1 A stepwise development of CRC includes ACF, adenoma, and adenocarcinoma formation which eventually metastasize. ACFs preneoplastic lesions are develop when an insult occurs in the colonic mucosa upon…
Immunopathology of Hepatobiliary Tumors and Immunotherapy of Liver Cancers
Fig. 10.1 Schematic presentation of immune cells in the cancer microenvironment In the setting of hepatocarcinogenesis, the most important predisposing factor is chronic HBV infection. The genome of HBV alters…
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoe
Fig. 16.1 MRI scan, horizontal layer at the level of the basis of the tongue, presenting the tumor area at the right site and a group of lymph nodes at…
Immunology and Immunotherapy of Graft-Versus-Host Disease
Fig. 24.1 Pathogenesis of graft-versus-host disease (GVHD) can be divided into three phases. In the first phase, the host is conditioned by myeloablative treatment. This leads to tissue damage with…
Immunology and Immunotherapy of Breast Cancer
© Springer-Verlag Berlin Heidelberg 2015Nima Rezaei (ed.)Cancer Immunology10.1007/978-3-662-46410-6_23 23. Immunology and Immunotherapy of Breast Cancer John Stagg1 and Sherene Loi2 (1) Centre de Recherche du Centre Hospitalier de l’Université de Montréal, 900 St-Denis Street Montreal, Montreal,…
Immunology and Immunotherapy of Ovarian Cancer
29. Bennaceur K, Chapman JA, Touraine J-l, Portoukalian J. RETRACTED: immunosuppressive networks in the tumour environment and their effect in dendritic cells. Biochi Biophys Acta (BBA)-Rev Cancer. 2009;1795(1):16–24. 30. Kalluri…
Immunopathology of Specific Cancers in Males and Females and Immunotherapy of Prostate and Cervical Cancer
4. Chakrabarti A, Verbridge S, Stroock AD, Fischbach C, Varner JD. Multiscale models of breast cancer progression. Ann Biomed Eng. 2012;40:2488–500.PubMed 5. Taddei ML, Giannoni E, Comito G, Chiarugi P….
